News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Replicate Bioscience, Inc.
NEWS
JOBS
IN THE PRESS
NEWS
Business
Replicate Launches with $40 Million to Eliminate Drug Resistance in Cancer
Replicate focuses on using self-replicating RNA (srRNA) to develop therapies for autoimmune and inflammatory diseases and prevent drug resistance in cancer.
September 8, 2021
·
3 min read
·
Mark Terry
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Drug Development
Replicate Bioscience Presents Positive Data from Phase 1 Trial and Preclinical Data with Novel Self-Replicating RNA at the 2024 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
May 11, 2024
·
4 min read
Biotech Beach
Replicate Bioscience Announces Oral Presentations at the 2024 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
April 22, 2024
·
2 min read
Biotech Beach
Replicate Bioscience to Participate in Upcoming Investor and Scientific Conferences
March 1, 2024
·
2 min read
Drug Development
Replicate Bioscience Announces Positive Initial Clinical Results for its Next Generation srRNA Technology
February 14, 2024
·
4 min read
Biotech Beach
Replicate Bioscience to Present Progress on Two srRNA Oncology Programs at Society for Immunotherapy of Cancer 2023 Meeting
October 31, 2023
·
3 min read
Drug Development
Curia Supports Replicate Bioscience’s Phase 1 Clinical Trial of Novel Next-Generation RNA VaccineSupply of drug substance manufactured under cGMP supports first-in-human clinical study for RBI-4000 novel self-replicating RNA (srRNA)
September 13, 2023
·
2 min read
Drug Development
Replicate Bioscience Initiates a Phase 1 Trial of its Next-Generation srRNA Vaccine
September 12, 2023
·
3 min read
Business
Replicate Bioscience Appoints Rachael Lester as Chief Business Officer
July 10, 2023
·
3 min read
Biotech Beach
Replicate Bioscience Presents Preclinical srRNA Data at the American Association for Cancer Research Annual Meeting 2023
April 19, 2023
·
4 min read
Biotech Beach
Replicate Bioscience Shares New Preclinical srRNA Data at American Association for Cancer Research Annual Meeting 2023
March 14, 2023
·
3 min read
